The FDA and Nebraska health authorities issued warnings after patients became seriously ill following treatment with exosomes, an unproven, potentially risky and, per the FDA, illegal product being promoted by dubious stem cell clinics.
The FDA may strengthen homeopathic drug regulation with its "risk-based" enforcement policy, but this still leaves illegal homeopathic remedies on the market and falls far short of actually enforcing the law.
Drug shortages, which worsen medical care and patient outcomes, are becoming more and more common. A new Task Force report from the FDA offers a potential way forward.
Based on a thorough review of the evidence by experts, the FDA is proposing a ban on using curcumin, cesium chloride and other naturopathic favorites in compounded drugs.
Generic drugs are supposed to be equivalent to brand-name drugs, but all too often they are defective. Katherine Eban's book shows that corrupt overseas manufacturers have committed intentional global fraud. The system is broken and the FDA lacks the power to correct abuses.
There's no reliable evidence that an infusion of blood plasma from a young donor will benefit an older person, and there are risks, but Ambrosia Health is selling "young blood" infusions for thousands of dollars anyway. The FDA has taken notice.
The Food and Drug Administration just won a court case supporting the agency's ability to regulate stem cell clinics that rely on client-derived adipose tissues. This is a win for consumer protection, though too late to help those already harmed.
A lawsuit claiming Walmart fraudulently deceives consumers in the sale of worthless homeopathic remedies has been filed by the Center for Inquiry (CFI), acting on behalf of the general public. CFI says co-mingling ineffective homeopathic products with science-based treatments on Walmart's pharmacy shelves and website misleads customers into thinking they are equivalent, when "there is not a shred of credible scientific evidence"...
Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a countervailing pressure to approve new drugs rapidly, particularly in cancer. That's why the FDA created the accelerated approval program in the early 1990s. Unfortunately, increasingly this approval process appears to be failing us in oncology. Reform is needed.
The FDA reminds everyone that (no matter what your state says) CBD is not a legal ingredient in dietary supplements and foods. The agency is willing to explore changes to the law but unproven claims for CBD health benefits, such cancer cures, will not be tolerated.